Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 28, 2018; 24(4): 484-493
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.484
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.484
Figure 1 Flow diagram shows the selection of hepatocellular carcinoma patients.
HCC: Hepatocellular carcinoma; RFA: Radiofrequency ablation; LR: Liver resection; LT: Liver transplantation; TACE: Transarterial chemoembolization.
- Citation: Meng XC, Chen BH, Huang JJ, Huang WS, Cai MY, Zhou JW, Guo YJ, Zhu KS. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. World J Gastroenterol 2018; 24(4): 484-493
- URL: https://www.wjgnet.com/1007-9327/full/v24/i4/484.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i4.484